MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Elementis swings to loss on pandemic impact

StockMarketWire.com

Chemicals and personal care businesses Elementis swung to an annual loss, pinned on a Covid-19 related volume impact across industrial and consumer end markets.

For 2020, pre-tax loss was $68.8 million compared with a profit of $61 million year-on-year as revenue fell 14% to $751 million.

Looking ahead, the company said it continued to see demand improvement and had made an encouraging start to 2021, but remained cautious on its outlook due to COVID-19 dynamic.

'We have made an encouraging start to 2021, and for the full year expect improved financial performance and deleveraging, linked to COVID-19 developments,' the company said.

'We will continue to maintain our focus on self-help actions to optimise performance, and in 2021 expect to deliver more than $30m of new business opportunities, over 20 new products and $10m of cost savings,' it added. Story provided by StockMarketWire.com